Two of Sanofi’s lunsekimig Phase II trials have met their primary endpoints in respiratory disease, while a study in atopic ...

Sanofi’s TSLP and IL-13 inhibitor has aced a pair of mid-stage studies for respiratory diseases, but missed on a phase 2 ...

Patients with respiratory conditions, such as asthma and COPD, are being encouraged to use apps to manage their symptoms.

Sanofi’s (SNY) lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP, the company said on Tuesday. Lunsekimig, a novel bispecific Nanobody VHH, is made ...

Clinicians can reasonably include Mediterranean-style eating in respiratory prevention counseling — alongside smoking ...

Credit: Getty Images Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the classic male presentation. Despite decades of advances in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. This year’s top asthma and respiratory disorder story ...

Respiratory diseases and allergic conditions encompass a diverse group of disorders that affect millions globally. These conditions, which include asthma, allergic rhinitis, atopic dermatitis and ...

Please provide your email address to receive an email when new articles are posted on . Wildfire smoke includes particle pollution that can penetrate deep into the lungs. Patients with asthma should ...

A handful of North American companies which see potential for vape-like devices to ease migraines and respiratory diseases such as asthma have a long road to convince health authorities and patients ...

Sonia Gandhi’s bronchial asthma diagnosis highlights key triggers like air pollution, infections, and allergens. Know the top ...